Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 4Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 3Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 100Leukemia, Myeloid, Acute 79Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Myeloproliferative Disorders 40Leukemia, Myelogenous, Chronic, BCR-ABL Positive 37Leukemia, Myelomonocytic, Chronic 32Primary Myelofibrosis 30Lymphoma, Non-Hodgkin 30Polycythemia Vera 19Lymphoma 15Leukemia 15Hematologic Neoplasms 15Leukemia, Biphenotypic, Acute 14Thrombocythemia, Essential 13Multiple Myeloma 11Hodgkin Disease 11Histiocytosis, Langerhans-Cell 11Neoplasms 10Leukemia, Myeloid, Chronic-Phase 10Leukemia, Lymphocytic, Chronic, B-Cell 10Rhabdoid Tumor 9Neuroblastoma 9Medulloblastoma 9Glioma 9Ependymoma 9Anemia, Refractory, with Excess of Blasts 9Wilms Tumor 8Sarcoma 8Rhabdomyosarcoma 8Osteosarcoma 8

Interventions

itacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Plasma Cell × Myeloid × Clear all
NCT05823571 2025-09-18

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Active not recruiting
32 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Leukemia, Plasma Cell, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡